Tivity Health Inc (NASDAQ:TVTY) Expected to Post Earnings of $0.66 Per Share

Share on StockTwits

Equities research analysts forecast that Tivity Health Inc (NASDAQ:TVTY) will post $0.66 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Tivity Health’s earnings, with the highest EPS estimate coming in at $0.74 and the lowest estimate coming in at $0.54. Tivity Health posted earnings per share of $0.53 in the same quarter last year, which would suggest a positive year over year growth rate of 24.5%. The company is expected to announce its next quarterly earnings report on Thursday, August 1st.

According to Zacks, analysts expect that Tivity Health will report full-year earnings of $2.35 per share for the current year, with EPS estimates ranging from $2.25 to $2.40. For the next year, analysts anticipate that the firm will report earnings of $2.49 per share, with EPS estimates ranging from $1.95 to $2.73. Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that that provide coverage for Tivity Health.

Tivity Health (NASDAQ:TVTY) last posted its quarterly earnings data on Wednesday, May 8th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.01. The company had revenue of $214.10 million during the quarter, compared to analyst estimates of $200.39 million. Tivity Health had a return on equity of 26.02% and a net margin of 12.18%. The firm’s quarterly revenue was up 42.8% on a year-over-year basis. During the same quarter last year, the company earned $0.49 earnings per share.

Several research firms recently issued reports on TVTY. Piper Jaffray Companies lifted their price objective on Tivity Health from $29.00 to $33.00 and gave the company an “overweight” rating in a research note on Thursday, May 9th. BidaskClub lowered Tivity Health from a “sell” rating to a “strong sell” rating in a research note on Monday, March 11th. Jefferies Financial Group dropped their price objective on Tivity Health to $29.00 and set a “buy” rating for the company in a research note on Wednesday, February 20th. Zacks Investment Research raised Tivity Health from a “hold” rating to a “strong-buy” rating and set a $25.00 price objective for the company in a research note on Wednesday, May 1st. Finally, Oppenheimer lifted their price objective on Tivity Health from $31.00 to $36.00 in a research note on Thursday, May 9th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $33.00.

NASDAQ:TVTY opened at $18.16 on Tuesday. The company has a market capitalization of $869.57 million, a price-to-earnings ratio of 7.76, a price-to-earnings-growth ratio of 0.75 and a beta of 1.21. Tivity Health has a 52-week low of $16.25 and a 52-week high of $41.46. The company’s fifty day simple moving average is $19.38. The company has a quick ratio of 0.71, a current ratio of 0.86 and a debt-to-equity ratio of 2.13.

In other news, Director Bradley S. Karro purchased 2,900 shares of the stock in a transaction on Friday, March 22nd. The shares were acquired at an average price of $16.54 per share, for a total transaction of $47,966.00. Following the completion of the transaction, the director now directly owns 24,696 shares of the company’s stock, valued at approximately $408,471.84. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Sara Finley purchased 2,000 shares of the stock in a transaction on Wednesday, March 20th. The shares were purchased at an average price of $17.25 per share, for a total transaction of $34,500.00. The disclosure for this purchase can be found here. Company insiders own 1.64% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TVTY. Advisor Group Inc. increased its holdings in shares of Tivity Health by 364.2% in the fourth quarter. Advisor Group Inc. now owns 1,142 shares of the company’s stock worth $29,000 after buying an additional 896 shares during the period. Enlightenment Research LLC purchased a new position in shares of Tivity Health in the fourth quarter worth about $37,000. Shell Asset Management Co. purchased a new position in shares of Tivity Health in the first quarter worth about $33,000. Pearl River Capital LLC purchased a new position in shares of Tivity Health in the first quarter worth about $36,000. Finally, Asset Dedication LLC purchased a new position in shares of Tivity Health in the first quarter worth about $46,000.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Article: How to use beta for portfolio diversification

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.